Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 447038Generated: October 27, 2026

4-(6-(Tributylstannyl)pyridin-2-yl)morpholine → 1-Ethyl-3-[7-(6-morpholin-4-yl-pyridin-2-yl)-5-pyridin-3-yl-benzothiazol-2-yl]-urea

https://huagongshe.com/reaction/447038

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(6-(Tributylstannyl)pyridin-2-yl)morpholineHCID 18525739—
Reactant1-(7-Iodo-5-pyridin-3-yl-benzothiazol-2-yl)-3-ethyl-ureaHCID 24864395—
CatalystHCID 178418397HCID 178418397—
SolventDimethylformamideHCID 6228—
Product1-Ethyl-3-[7-(6-morpholin-4-yl-pyridin-2-yl)-5-pyridin-3-yl-benzothiazol-2-yl]-ureaHCID 578135686.2%

Reaction Conditions

Temperature120 °C

Reaction Steps

To a solution of 1-(7-iodo-5-pyridin-3-yl-benzothiazol-2-yl)-3-ethyl-urea (0.15 g, 0.35 mmol) in DMF (5 mL) was added 4-(6-tributylstannanyl-pyridin-2-yl)-morpholine (0.30 g, 0.70 mmol) under nitrogen atmosphere at room temperature. The reaction mixture was then degassed for half an hour followed by the addition of tetrakis(triphenylphosphine)palladium(0) (0.020 g, 0.018 mmol). The reaction mixture was then again degassed for half an hour and heated at 120° C. for 15 h under nitrogen atmosphere. After the completion of the reaction (TLC monitoring), DMF was distilled off; water was added to the reaction mixture and extracted with ethyl acetate. The combined organic layers were dried over anhydrous Na2SO4, and evaporated to dryness under reduced pressure. The crude residue was purified by prep HPLC to get the title compound (0.01 g, 6.0%) as white solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08481544B2
Source datasetuspto-grants-2013_07
ORD IDord-cfa2dc536200437ead881969a0c5a45d
Source noteuspto-grants-2013_07